Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Esophageal Neoplasms 3 Brain Neoplasms 3 Sarcoma 2 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Osteosarcoma 2 Craniopharyngioma 2 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Vascular Neoplasms 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Recurrent Head and Neck Carcinoma 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Neoplasms 1 Myoepithelioma 1 Mesothelioma, Malignant 1 Meningioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Hodgkin Disease 1 Histiocytoma, Angiomatoid Fibrous 1 Hemangiosarcoma 1

Interventions

Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 tazemetostat 1 pembrolizumab 1 atezolizumab 1 X-Rays 1 Tiragolumab 1 Proton Therapy 1 Phantoms, Imaging 1 Fluorodeoxyglucose F18 1 Cetuximab 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chordoma × Proton Therapy × 90 days × Clear all

NCT00496119 2026-06-12

Proton Beam Therapy for Chordoma Patients

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡